Glasgow, United Kingdom

ESTRO 2024

It is my great pleasure to invite you to ESTRO 2024 which will take place from 3 to 7 May in Glasgow, United Kingdom.

The ambition of ESTRO to further reinforce radiation oncology as a core partner in multidisciplinary cancer care, and to guarantee accessible and high-value radiation therapy for all cancer patients who need it, is expressed in the society’s vision statement for 2030: ‘Radiation Oncology. Optimal Health for All, Together.’

Building on previous congresses, the next step towards this goal is to reflect and act on the radiotherapy opportunities and challenges brought on, and brought to light, around the world in recent years. With this aim, the congress theme is Radiation Oncology: Bridging the Care Gap.

The programme will take a comprehensive look at where radiotherapy is today and where it is going, as well as focussing on where we can bridge gaps in provision of optimal radiotherapy to all. The theme will be reflected throughout the programme via state-of-the-art sessions. Along with symposia, debates and teaching lectures, the scientific programme will feature panel discussions and pitch sessions. Joint sessions with partner associations will connect delegates with new communities and increase the reach of the ESTRO population. Fostering the development of young radiation oncology professionals remains a top priority for ESTRO and therefore the Young Track will continue to provide educational activities focussed on those in the earlier stages of their careers. All sessions will promote the interaction between faculty and audience.

We will continue to optimise the contributions from submitted abstracts. The best abstract submitted to each track will be celebrated in the Best Proffered Papers plenary session. Other sessions will showcase the Latest Clinical Trials and Late-breaking Papers. The highly popular mini-oral sessions will continue, enhancing the visibility of your submitted research, while poster discussion sessions offer you a platform to showcase your work. We will continue to emphasise the interdisciplinarity of the ESTRO scientific programme by calling for abstracts which are of interest to a broad range of disciplines.

Networking with corporate partners is always invaluable. ESTRO 2024 will host Europe’s largest industry exhibition in radiation oncology. It will offer you a unique opportunity to interact with industry leaders and to find out about the latest developments in technology, techniques and oncology products.

We look forward to welcoming you in Glasgow.

With warm regards,

 

anna-kirby-2.jpg

       Anna Kirby                                                
      ESTRO President
      ESTRO 2024 Chair  

ESTRO 2024 has been accredited with 25 European CME credits (ECMEC®s) by the European Accreditation Council for Continuing Medical Education (EACCME®). The EACCME® is an institution of the European Union of Medical Specialists (UEMS), www.uems.eu.

Each medical specialist should claim only those credits that they actually spent in the educational activity.

Through an agreement between the European Union of Medical Specialists and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 Credits™.  Information on the process to convert EACCME® credits to AMA credits can be found at https://edhub.ama-assn.org/pages/applications.

Live educational activities occurring outside of Canada, recognised by the UEMS-EACCME® for ECMEC® credits are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.

Information regarding the conversion of EACCME® credits

Credit will be converted based on one (1) hour of participation equalling one credit for all activities. Physicians wishing to convert EACCME® credits to AMA PRA Category 1 Credit™ will be required to access the AMA website at https://edhub.ama-assn.org/pages/applictations to obtain the necessary paperwork and instructions. Physicians and other health care professionals will be required to pay a processing fee to the AMA.

For other countries, please contact the relevant national/regional accreditation authority.